6 research outputs found
Barrett's esophagus: Origin, development and options for therapeutic intervention
Barrett’s esophagus (BE) consists of a metaplasia in which the normal squamous
cells lining the esophagus are replaced by a mixture of gastric and intestinal lining
cells. The intestinal-type lining cells are often referred to as specialized columnar
cells and include e.g. goblet cells. For a number of years, some scientists thought
that there were two types of BE; one in which the normal lining was replaced with
gastric type cells only, and the second in which intestinal cells were present. Presently,
intestinal metaplasia is required for the diagnosis of BE because intestinal
metaplasia is the only type of esophageal columnar epithelium that clearly predisposes
to malignancy.
BE is a complication of chronic gastroesophageal reflux disease (GERD), primarily
in white men. GERD is a disease in which there is reflux of acidic fluid from the
stomach and bile contents from the duodenum into the esophagus. It most commonly
causes heartburn, but many patients do not have any symptoms
Expression, localization and polymorphisms of the nuclear receptor PXR in Barrett's esophagus and esophageal adenocarcinoma
Background: The continuous exposure of esophageal epithelium to refluxate may induce ectopic expression of bile-responsive genes and contribute to the development of Barrett's esophagus (BE) and esophageal adenocarcinoma. In normal physiology of the gut and liver, the nuclear receptor Pregnane × Receptor (PXR) is an important factor in the detoxification of xenobiotics and bile acid homeostasis. This study aimed to investigate the expression and genetic variation of PXR in reflux esophagitis (RE), Barrett's esophagus (BE) and esophageal adenocarcinoma.Methods: PXR mRNA levels and protein expression were determined in biopsies from patients with adenocarcinoma, BE, or RE, and healthy controls. Esophageal cell lines were stimulated with lithocholic acid and rifampicin. PXR polymorphisms 25385C/T, 7635A/G, and 8055C/T were genotyped in 249 BE patients, 233 RE patients, and 201 controls matched for age and gender.Results: PXR mRNA levels were significantly higher in adenocarcinoma tissue and columnar Barrett's epithelium, compared to squamous epithelium of these BE patients (P < 0.001), and RE patients (P = 0.003). Immunohistochemical staining of PXR showed predominantly cytoplasmic expression in BE tissue, whereas nuclear expression was found in adenocarcinoma tissue. In cell lines, stimulation with lithocholic acid did not increase PXR mRNA levels, but did induce nuclear translocation of PXR protein. Genotyping of the PXR 7635A/G polymorphism revealed that the G allele was significantly more prevalent in BE than in RE or controls (P = 0.037).Conclusions: PXR expresses in BE and adenocarcinoma tissue, and showed nuclear localization in adenocarcinoma tissue. Upon stimulation with lithocholic acid, PXR translocates to the nuclei of OE19 adenocarcinoma cells. Together with the observed association of a PXR polymorphism and BE, this data implies that PXR may have a function in prediction and treatment of esophageal disease
583 MYO9B Polymorphisms and Expression As Predictors for the Risk of Barrett's Esophagus and Esophageal Adenocarcinoma in Reflux Patients
173 Reduced Epidermal Growth Factor (EGF) Expression Is Associated with An Increased Risk for the Reflux-Induced Cascade Causing Barrett's Esophagus and Esophageal Adenocarcinoma
Conversion of metaplastic Barrett's epithelium into post-mitotic goblet cells by γ-secretase inhibition
Barrett's esophagus (BE) affects approximately 2% of the Western population and progresses to esophageal adenocarcinoma (EAC) in 0.5% of these patients each year. In BE, the stratifie
Functional single-nucleotide polymorphism of epidermal growth factor is associated with the development of Barrett's esophagus and esophageal adenocarcinoma
Reflux esophagitis (RO) and Barrett's esophagus (BO) can cause esophageal adenocarcinoma (OAC). The esophageal mucosa in the RO-BO-OAC cascade is chronically exposed to gastro-esophageal reflux. Epidermal growth factor (EGF) has an important role in the protection and repair of mucosal damage, and non-physiologic levels are associated with gastrointestinal tumors. The aim is to determine the functional effect of EGF gene polymorphisms on RO, BO and OAC development. A cohort of 871 unrelated Dutch Caucasians consisted of 198 healthy controls, 298 RO patients, 246 BO patients and 129 OAC patients. The frequency of the EGF-production-associated 5'UTR A+61G polymorphism was determined in these four groups. EGF immunohistochemistry was performed on BO biopsies. EGF expression was significantly lower in the G/G genotype compared with the A/G (P=0.008) and A/A (P=0.002) group. The G/G genotype was significantly more prevalent in RO (odds ratios (OR)=2.6; 95% confidence intervals (95% Cl): 1.3-5.2), BO (OR=3.0; 95% Cl: 1.5-6.2) and OAC (OR=4.1; 95% Cl: 1.8-9.7) than in controls. The G allele is associated with reduced EGF expression and increased risk for RO, BO and OAC development. This indicates that reduced mucosal protection resulting from genetically decreased EGF expression enhances esophageal tumor development. Journal of Human Genetics (2012) 57, 26-32; doi: 10.1038/jhg.2011.124; published online 1 December 201